DrugPatentWatch Database Preview
ESKATA Drug Profile
Which patents cover Eskata, and what generic alternatives are available?
Eskata is a drug marketed by Aclaris and is included in one NDA. There are four patents protecting this drug.
This drug has twenty-seven patent family members in fifteen countries.
The generic ingredient in ESKATA is hydrogen peroxide. There are fifty-three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydrogen peroxide profile page.
US ANDA Litigation and Generic Entry Outlook for Eskata
Eskata was eligible for patent challenges on December 31, 1968.
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be December 14, 2020. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
Summary for ESKATA
| International Patents: | 27 |
| US Patents: | 4 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 102 |
| Patent Applications: | 5,031 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ESKATA at DailyMed |
Generic Entry Opportunity Date for ESKATA
Generic Entry Date for ESKATA*:
Constraining patent/regulatory exclusivity:
NEW PRODUCT NDA:
Dosage:
SOLUTION;TOPICAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Synonyms for ESKATA
| [OH(OH)] |
| 218625-72-0 |
| 30 %Hydrogen peroxide(aq) |
| 37355-84-3 |
| 66554-50-5 |
| 7722-84-1 |
| 8007-30-5 |
| 97929-73-2 |
| AC1L1A0N |
| Accel Concentrate |
| ACMC-20akqy |
| Adeka Super EL |
| AKOS015856794 |
| Albone |
| Albone 35 |
| Albone 35CG |
| Albone 50 |
| Albone 50CG |
| Albone 70 |
| Albone 70CG |
| Albone DS |
| Anti-Keim 50 |
| Asepticper |
| Astri-UC |
| Baquashock |
| BBX060AN9V |
| bis(hydridooxygen)(O--O) |
| C00027 |
| Caswell No. 486AAA |
| CCRIS 1060 |
| CHEBI:16240 |
| CHEMBL71595 |
| CIX |
| Clarigel Gold |
| Crestal Whitestrips |
| Crystacide |
| CTK2H7501 |
| D00008 |
| DB11091 |
| Dentasept |
| Deslime LP |
| Dihydrogen dioxide |
| dihydrogen peroxide |
| dihydrogen(peroxide) |
| dioxidane |
| DTXSID2020715 |
| EC 231-765-0 |
| EINECS 231-765-0 |
| Elawox |
| EPA Pesticide Chemical Code 000595 |
| FT-0627133 |
| H2O2 |
| High Test Peroxide |
| Hioxy |
| Hioxyl |
| Hipox |
| HOOH |
| HSDB 547 |
| HTP [peroxide] |
| Hybrite |
| Hydrogen dioxide |
| Hydrogen dioxide solution |
| hydrogen hydroperoxide |
| hydrogen per oxide |
| hydrogen peroxide |
| Hydrogen peroxide (> 52% conc.) |
| Hydrogen peroxide (8CI) |
| Hydrogen peroxide (conc > 52%) |
| Hydrogen peroxide (conc >52%) |
| Hydrogen peroxide (H2O2) |
| Hydrogen peroxide (H2O2) (9CI) |
| Hydrogen peroxide (USP) |
| Hydrogen Peroxide [Topical Solution] |
| Hydrogen peroxide [USP] |
| Hydrogen peroxide 15% |
| Hydrogen peroxide 35% |
| Hydrogen peroxide 50% |
| Hydrogen peroxide solution |
| Hydrogen peroxide solution (DOT) |
| Hydrogen peroxide solution, >=30%, for trace analysis |
| Hydrogen peroxide solution, 3%, for microbiology |
| Hydrogen peroxide solution, 30 % (w/w) in H2O, contains stabilizer |
| Hydrogen Peroxide Solution, 30% (w/w), puriss. p.a., reag. ISO, reag. Ph. Eur. |
| Hydrogen peroxide solution, 50 wt. % in H2O, stabilized |
| Hydrogen peroxide solution, AR, contains sodium pyrophosphate as stabilizer, >=30 % (w/v) |
| Hydrogen peroxide solution, contains ~200 ppm acetanilide as stabilizer, 3 wt. % in H2O |
| Hydrogen peroxide solution, contains inhibitor, 30 wt. % in H2O, ACS reagent |
| Hydrogen peroxide solution, contains inhibitor, 30 wt. % in H2O, meets USP testing specifications |
| Hydrogen peroxide solution, contains inhibitor, 35 wt. % in H2O |
| Hydrogen peroxide solution, contains potassium stannate as inhibitor, 30-32 wt. % in water, semiconductor grade, 99.999% trace metals basis |
| Hydrogen peroxide solution, extra pure, 30.0-32.0% |
| Hydrogen peroxide solution, for ultratrace analysis |
| Hydrogen peroxide solution, JIS special grade, 30.0-35.5% |
| Hydrogen peroxide solution, LR, contains sodium pyrophosphate as stabilizer, >=30 % (w/v) |
| Hydrogen peroxide solution, LR, contains sodium pyrophosphate as stabilizer, >=50 % (w/v) |
| Hydrogen peroxide solution, meets analytical specification of Ph. Nord., 34.5-36.5% |
| Hydrogen peroxide solution, p.a., ACS reagent, reag. ISO, 30.0% |
| Hydrogen peroxide solution, puriss. p.a., ACS reagent, not stabilized, >=30% (RT) |
| Hydrogen peroxide solution, purum p.a., >=30% (RT) |
| Hydrogen peroxide solution, purum p.a., >=35% (RT) |
| Hydrogen peroxide solution, SAJ first grade, >=30.0% |
| Hydrogen peroxide solution, semiconductor grade MOS PURANAL(TM) (Honeywell 17937), >=30% |
| Hydrogen peroxide solution, semiconductor grade PURANAL(TM) (Honeywell 17948), >=30% |
| Hydrogen peroxide solution, semiconductor grade ULSI PURANAL(TM) (Honeywell 17024), >=30% |
| Hydrogen peroxide solution, semiconductor grade VLSI PURANAL(TM) (Honeywell 17606), >=30% |
| Hydrogen peroxide solution, tested according to Ph.Eur. |
| Hydrogen peroxide solutions |
| Hydrogen peroxide solutions (over 60% but not over 70%) |
| Hydrogen peroxide solutions (over 8% but not over 60%) |
| Hydrogen peroxide, 20% to 60% |
| Hydrogen peroxide, 3 wt.% solution in water, stabilized |
| Hydrogen peroxide, 3% |
| Hydrogen peroxide, 30% |
| Hydrogen Peroxide, 50% |
| Hydrogen peroxide, 6% in water |
| Hydrogen peroxide, 8% to 20% |
| Hydrogen peroxide, 90% |
| HYDROGEN PEROXIDE, ACS |
| Hydrogen peroxide, ACS reagent, 30 wt% solution in water, nonstabilized |
| Hydrogen peroxide, aqueous solutions with >40% but not >60% hydrogen peroxide (stabilized as necessary) |
| Hydrogen peroxide, aqueous solutions with >40% but not >60% hydrogen peroxide (stabilized as necessary) [UN2014] [Oxidizer] |
| Hydrogen peroxide, aqueous solutions with >40% but not >60% hydrogen peroxide (stabilized as necessary) [UN2014] [Oxidizer] |
| Hydrogen peroxide, aqueous solutions with not <20% but not >40% hydrogen peroxide (stabilized as necessary) |
| Hydrogen peroxide, aqueous solutions with not <20% but not >40% hydrogen peroxide (stabilized as necessary) [UN2014] [Oxidizer] |
| Hydrogen peroxide, aqueous solutions with not <20% but not >40% hydrogen peroxide (stabilized as necessary) [UN2014] [Oxidizer] |
| Hydrogen peroxide, aqueous solutions with not <8% but <20% hydrogen peroxide (stabilized as necessary) |
| Hydrogen peroxide, aqueous solutions with not <8% but <20% hydrogen peroxide (stabilized as necessary) [UN2984] [Oxidizer] |
| Hydrogen peroxide, aqueous solutions with not <8% but <20% hydrogen peroxide (stabilized as necessary) [UN2984] [Oxidizer] |
| Hydrogen peroxide, pure, 50 wt% solution in water, stabilized |
| Hydrogen peroxide, solution |
| Hydrogen peroxide, solution 30% |
| Hydrogen peroxide, solution, 3% |
| Hydrogen peroxide, solution, 30% |
| Hydrogen peroxide, solution, 35% |
| Hydrogen peroxide, stabilized or hydrogen peroxide aqueous solutions, stabilized with >60% hydrogen peroxide |
| Hydrogen peroxide, stabilized or hydrogen peroxide aqueous solutions, stabilized with >60% hydrogen peroxide [UN2015] [Oxidizer] |
| Hydrogen peroxide, stabilized or hydrogen peroxide aqueous solutions, stabilized with >60% hydrogen peroxide [UN2015] [Oxidizer] |
| Hydrogen peroxide, technical, 35 wt% solution in water, stabilized |
| HYDROGEN-PEROXIDE |
| hydrogenperoxide |
| hydroperoxide |
| I14-62939 |
| Inhibine |
| Interox |
| Kastone |
| Lase Peroxide |
| Lensan A |
| Lensept |
| LS-2428 |
| Magic Bleaching |
| Metrokur |
| MFCD00011333 |
| MHAJPDPJQMAIIY-UHFFFAOYSA-N |
| Mirasept |
| MolMap_000025 |
| MolPort-003-927-052 |
| Nite White Excel 2 |
| NSC 19892 |
| NSC-19892 |
| NSC19892 |
| O-O |
| Odosat D |
| Opalescence Xtra |
| Oxigenal |
| oxydol |
| Oxydol (JP17) |
| Oxyfull |
| Oxyfull (TN) |
| Oxysept |
| Oxysept I |
| Pegasyl |
| PEO |
| perhydrol |
| Perone |
| Perone 30 |
| Perone 30 Perone 35 |
| Perone 35 |
| Perone 50 |
| Perossido di idrogeno |
| Perossido di idrogeno [Italian] |
| Peroxaan |
| Peroxan |
| Peroxclean |
| Peroxide |
| Peroxide Ion |
| Peroxyde d'hydrogene |
| Peroxyde d'hydrogene [French] |
| Pre milk HP 0.5 |
| Pre milk HP 0.5 10 |
| Pre milk HP 1.0 |
| Puresept |
| QTL1_000041 |
| Quasar Brite |
| RL04954 |
| Select Bleach |
| Superoxol |
| T-Stuff |
| Teat dip HP 5 |
| TR-037767 |
| UN 2014 (20%-52%) |
| UN 2015 (>52%) |
| UN 2984 (8%-20%) |
| UN2014 |
| UN2015 |
| UN2984 |
| UNII-BBX060AN9V |
| UNL-UNL |
| Wasserstoffperoxid |
| Wasserstoffperoxid [German] |
| Waterstofperoxyde |
| Waterstofperoxyde [Dutch] |
| Whiteness HP |
| Whitespeed |
| WLN: H2 O2 90% |
| Xtra White |
US Patents and Regulatory Information for ESKATA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aclaris | ESKATA | hydrogen peroxide | SOLUTION;TOPICAL | 209305-001 | Dec 14, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Aclaris | ESKATA | hydrogen peroxide | SOLUTION;TOPICAL | 209305-001 | Dec 14, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Aclaris | ESKATA | hydrogen peroxide | SOLUTION;TOPICAL | 209305-001 | Dec 14, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Aclaris | ESKATA | hydrogen peroxide | SOLUTION;TOPICAL | 209305-001 | Dec 14, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ESKATA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2437823 | Start Trial |
| European Patent Office | 3134061 | Start Trial |
| New Zealand | 527673 | Start Trial |
| Japan | 6622217 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ESKATA
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0605697 | SPC/GB01/008 | United Kingdom | Start Trial | PRODUCT NAME: 1-(((3-(2-(DIMETHYLAMINO)ETHYL)INDOL-5-YL)METHYL)SULFONYL)PYRROLIDINE GENERIC NAME ALMOTRIPTAN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, ESPECIALLY AS ALMOTRIPTAN D,L - HYDROGEN MALATE; REGISTERED: ES 62.877 19991223; UK PL 16973/0005 20001026 |
| 0281459 | SPC/GB99/001 | United Kingdom | Start Trial | PRODUCT NAME: CLOPIDOGREL HYDROGEN SULPHATE, THE DEXTROROTATORY ISOMER OF ALPHA-(4,5,6,7-TETRAHYDROTHIENO(3,2-C)PYRID-5-YL)(2-CHLOROPHENYL) METHYL ACETATE AS THE HYDROGEN SULPHATE SALT; REGISTERED: UK EU/1/98/069/001 19980715; UK EU/1/98/069/002 19980715; UK EU/1/98/069/003 19980715 |
| 0302769 | 98C0036 | Belgium | Start Trial | PRODUCT NAME: CLOPIDOGREL HYDROGENE SULFATE; REGISTRATION NO/DATE IN FRANCE: EU/1/98 /069/001 DU 19980715; REGISTRATION NO/DATE AT EEC: DU EU/1-/98/069/001 |
| 0281459 | 98C0036 | France | Start Trial | PRODUCT NAME: CLOPIDOGREL HYDROGENE SULFATE; REGISTRATION NO/DATE IN FRANCE: EU/1/98 /069/001 DU 19980715; REGISTRATION NO/DATE AT EEC: DU EU/1-/98/069/001 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
